NDC properties for "testosterone enanthate 200 MG/ML Injectable Solution" (RxCUI 835809)
About this data
The tables show NDC propoerties for testosterone enanthate 200 MG/ML Injectable Solution with the RxCUI 835809
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for testosterone enanthate 200 MG/ML Injectable Solution (RxCUI 835809)
| ANDA | ANDA091120 |
|---|---|
| ANDA | ANDA212659 |
| MMSL_CODE | BD2948 |
| MMSL_CODE | CD2948 |
| MMSL_CODE | CD33833 |
| RxCUI | 835809 |
| SPL_SET_ID | 82a98132-9d5f-40a5-8c4f-f52f2a5de60e |
| SPL_SET_ID | e89d6458-428c-4256-97a3-f1fa851293c1 |
| VUID | 4001126 |
| VUID | 4016427 |
| Prescribable Synonym | testosterone enanthate 200 MG/ML Injectable Solution |
| RXNAV_STR | testosterone enanthate 200 MG/ML Injectable Solution |
| RxNorm Name | testosterone enanthate 200 MG/ML Injectable Solution |
| Related queries | Interactions (for RxCUI 835809) |
NDC Properties
NDC Item 00143975001
| NDC 9 | 0143-9750 |
|---|---|
| NDC 10 | 0143-9750-01 |
| NDC Item | 00143975001 |
| Packaging | 5 mL in 1 VIAL, MULTI-DOSE (0143-9750-01) |
| ANDA | ANDA091120 |
| DCSA | CIII |
| FDA SPL set id | 597193 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9750 |
NDC Item 00591322126
| NDC 9 | 0591-3221 |
|---|---|
| NDC 10 | 0591-3221-26 |
| NDC Item | 00591322126 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (0591-3221-26) / 5 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA085598 |
| DCSA | CIII |
| FDA SPL set id | 409092 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-12-31 |
| Marketing effective time low | 2011-05-04 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0591-3221 |
NDC Item 55150033601
| NDC 9 | 55150-336 |
|---|---|
| NDC 10 | 55150-336-01 |
| NDC Item | 55150033601 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-336-01) / 5 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA212659 |
| DCSA | CIII |
| FDA SPL set id | 773782 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-336 |
NDC Item 00143975001
| NDC 9 | 0143-9750 |
|---|---|
| NDC 10 | 0143-9750-01 |
| NDC Item | 00143975001 |
| Packaging | 5 mL in 1 VIAL, MULTI-DOSE (0143-9750-01) |
| ANDA | ANDA091120 |
| DCSA | CIII |
| FDA SPL set id | 597193 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9750 |
NDC Item 00591322126
| NDC 9 | 0591-3221 |
|---|---|
| NDC 10 | 0591-3221-26 |
| NDC Item | 00591322126 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (0591-3221-26) / 5 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA085598 |
| DCSA | CIII |
| FDA SPL set id | 409092 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-12-31 |
| Marketing effective time low | 2011-05-04 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0591-3221 |
NDC Item 55150033601
| NDC 9 | 55150-336 |
|---|---|
| NDC 10 | 55150-336-01 |
| NDC Item | 55150033601 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-336-01) / 5 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA212659 |
| DCSA | CIII |
| FDA SPL set id | 773782 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-336 |
NDC Item 00143975001
| NDC 9 | 0143-9750 |
|---|---|
| NDC 10 | 0143-9750-01 |
| NDC Item | 00143975001 |
| Packaging | 5 mL in 1 VIAL, MULTI-DOSE (0143-9750-01) |
| ANDA | ANDA091120 |
| DCSA | CIII |
| FDA SPL set id | 597193 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2012-09-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0143-9750 |
NDC Item 00591322126
| NDC 9 | 0591-3221 |
|---|---|
| NDC 10 | 0591-3221-26 |
| NDC Item | 00591322126 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (0591-3221-26) / 5 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA085598 |
| DCSA | CIII |
| FDA SPL set id | 409092 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2019-12-31 |
| Marketing effective time low | 2011-05-04 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 0591-3221 |
NDC Item 55150033601
| NDC 9 | 55150-336 |
|---|---|
| NDC 10 | 55150-336-01 |
| NDC Item | 55150033601 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-336-01) / 5 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA212659 |
| DCSA | CIII |
| FDA SPL set id | 773782 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-336 |